Mode
Text Size
Log in / Sign up
N/A N=138

Safety of Treatment of Shoulder Repair

Rotator Cuff

Enrolled (actual)
138
Serious AEs
14.5%
Results posted
Apr 2026
Primary outcome: Primary: Clinical Success Rate at 6 Months — 58; 68 Participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
HEALICOIL Knotless PEEK (Device); HEALICOIL Knotless REGENESORB (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Smith & Nephew, Inc.
Primary completion
May 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Clinical Success Rate at 6 Months
58; 68
SECONDARY
Clinical Success Rate at 12 Months
51; 63
SECONDARY
Clinical Success Rate at 24 Months (HEALICOIL Knotless REGENESORB Non-Self Tapping Suture Anchor ONLY)
27
SECONDARY
Constant-Murley Score
48.02; 44.93; 73.58; 67.94; 79.43; 74.40
SECONDARY
American Shoulder and Elbow Surgeons (ASES) Score
49.83; 46.13; 85.45; 83.79; 93.14; 89.63
SECONDARY
American Shoulder and Elbow Surgeons (ASES): Visual Analog Scale (VAS) Pain Score
5.24; 5.94; 1.73; 1.79; 0.90; 1.34
SECONDARY
Single Assessment Numeric Evaluation (SANE) Shoulder Scale at 6 Months and 12 Months
48.93; 45.59; 86.71; 86.31; 94.22; 93.03
SECONDARY
EuroQol (European Quality of Life) Five-dimensional Three-level (EQ-5D-3L): Index Score
0.82; 0.81; 0.93; 0.91; 0.95; 0.94
SECONDARY
EuroQol (European Quality of Life) Five-dimensional Three-level (EQ-5D-3L): Visual Analogue Scale (VAS) Score
76.81; 71.78; 86.06; 81.82; 84.65; 83.77
SECONDARY
Tendon Thickening at 6 Months and 24 Months (HEALICOIL Knotless REGENESORB Non-Self Tapping ONLY)
6.5; 6.3; 6.6; 6.0; 5.5; 6.1
SECONDARY
Tendon Re-tear Status at 6 Months and 24 Months (HEALICOIL Knotless REGENESORB Non-Self Tapping ONLY)
25; 5; 17; 5

Summary

This study evaluates the safety of the HEALICOIL Knotless Suture Anchors in patients requiring a repair of the rotator cuff tendon repair

Eligibility Criteria

Inclusion Criteria

  • Requires reattachment of soft tissue to bone for the following shoulder indications:
  • Rotator Cuff Tendon repair:
  • i. Single or double row rotator cuff repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping; OR
  • ii. Double row rotator cuff repair using HEALICOIL Knotless RG NST in lateral row (existing HEALICOIL RG device to be used in medial row of the repair); AND/OR
  • Biceps tenodesis
  • i. In conjunction with Rotator Cuff Tendon repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, HEALICOIL Knotless RG NST or HEALICOIL Knotless RG Self-Tapping OR
  • ii. As a stand-alone procedure for HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping (not HEALICOIL Knotless RG NST
  • Has a pre-operative MRI collected within 6 months of surgery which meets one of the following criteria:
  • MRI collected as standard-of-care has been submitted to external imaging vendor and confirmed as acceptable OR
  • If standard-of-care images are unavailable or considered unacceptable by external imaging vendor, subject must undergo an additional study-specific pre- operative MRI, confirmed as acceptable by external imaging vendor OR
  • MRI not required; subject not in HEALICOIL Knotless RG NST subgroup
  • Has consented to participate in the study by signing the IRB/IEC approved informed consent form.
  • Requires only one variant of the HEALICOIL Knotless Suture Anchor
  • Is ≥18 years of age at time of surgery
  • Willing and able to make all required study visits
  • Able to follow instructions (Approved translated documents supplied upon request)

Exclusion Criteria

Any one (1) of the following criteria will disqualify a potential subject from participation in the study:

  • Known hypersensitivity to the implant material. Where material sensitivity is suspected, appropriate tests should be made and sensitivity ruled out prior to implantation.
  • Pathological conditions of bone, such as cystic changes or severe osteopenia, which would compromise secure anchor fixation.
  • Pathological conditions in the soft tissues to be attached that would impair secure fixation by suture.
  • Comminuted bone surface, which would compromise secure anchor fixation.
  • Physical conditions which would eliminate, or tend to eliminate, adequate anchor support or retard healing
  • The presence of infection.
  • Conditions which would limit the subject's ability or willingness to restrict activities or follow directions during the healing period.
  • Concurrent bilateral surgery.
  • Participation in the treatment period of another clinical trial within thirty (30) days of Visit 1, or during the study.
  • Women who are pregnant.
  • Prior ipsilateral surgeries performed on the joint space.
  • Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04552119). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search